APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753UAB2. A total of 21 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,388 | +31.1% | 1,000 | 0.0% | 0.00% | – |
| Q1 2023 | $1,822 | +20.9% | 1,000 | 0.0% | 0.00% | – |
| Q4 2022 | $1,507 | -24.6% | 1,000 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | -100.0% | 1,000 | -100.0% | 0.00% | -100.0% |
| Q2 2022 | $12,459,000 | -5.6% | 8,325,000 | 0.0% | 0.00% | +33.3% |
| Q1 2022 | $13,203,000 | -4.4% | 8,325,000 | -8.9% | 0.00% | 0.0% |
| Q4 2021 | $13,816,000 | -19.3% | 9,138,000 | -34.5% | 0.00% | -25.0% |
| Q3 2021 | $17,120,000 | -34.5% | 13,960,000 | -1.6% | 0.00% | -33.3% |
| Q2 2021 | $26,151,000 | +226.7% | 14,183,000 | +148.8% | 0.01% | +200.0% |
| Q1 2021 | $8,004,000 | -42.1% | 5,701,000 | -30.8% | 0.00% | -33.3% |
| Q4 2020 | $13,812,000 | +51.5% | 8,233,000 | -2.2% | 0.00% | 0.0% |
| Q3 2020 | $9,117,000 | – | 8,420,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 28,825,000 | $35,498,000 | 0.69% |
| DeepCurrents Investment Group LLC | 15,079,000 | $18,525,000 | 0.55% |
| WOLVERINE ASSET MANAGEMENT LLC | 33,996,000 | $41,869,000 | 0.36% |
| Weiss Asset Management LP | 9,000,000 | $10,980,000 | 0.28% |
| SSI INVESTMENT MANAGEMENT LLC | 3,418,000 | $4,192,000 | 0.25% |
| Baker Brothers Advisors | 46,754,000 | $57,262,000 | 0.25% |
| MACKAY SHIELDS LLC | 15,855,000 | $19,641,000 | 0.18% |
| Verition Fund Management LLC | 4,310,000 | $5,350,000 | 0.05% |
| WESTWOOD HOLDINGS GROUP INC | 1,000,000 | $1,236,000 | 0.01% |
| GIRARD PARTNERS LTD. | 66,081 | $162,000 | 0.01% |